Track the AKTIS ONCOLOGY, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 10 July 2026 (Levée d'options). Among the most active insiders: Czibere Akos. Every trade is accessible without an account.
17
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2m
6 ops.
Sell Volume
19Σ signal
Buys ·€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
AKTIS ONCOLOGY, INC. is a company focused on developing innovative cancer treatments. It specializes in targeted therapies to improve patient outcomes.